Overview
Headquartered in Greater Boston in Lexington, Massachusetts, Agenus is a biotechnology company working in immuno-oncology. Immuno-oncology is a field that harnesses the power of the immune system to control or cure cancer. Through its research centers located in Lexington, Massachusetts, Basel, Switzerland and Jena, Germany, Agenus is developing a range of immunotherapies, including checkpoint modulators (CPMs), patient-specific anti-cancer vaccines, and vaccine adjuvants. CPM development is a particularly fast-moving field where early products produced unprecedented clinical benefits for patients. Agenus’ checkpoint modulator programs target GITR, OX40, CTLA-4, LAG-3, TIM-3 and PD-1. The company’s proprietary discovery engine Retrocyte Display® generates fully human therapeutic antibody drug candidates.
Founded in 1994, Agenus platforms are extensively partnered with GlaxoSmithKline, Janssen and Merck. Among Agenus and its partners, more than 20 programs are in clinical development.
At Agenus, we are dedicated to the development of life-changing medicines. Our employees solve complex problems through a culture of innovation, cross-functional teamwork, and commitment to our purpose. We are looking for people who are passionate about our mission and excited by the challenge of working as partners in a rapidly changing landscape.